欢迎来到天天文库
浏览记录
ID:54979268
大小:325.83 KB
页数:5页
时间:2020-05-07
《人工液胸或气胸辅助氩氦刀治疗膈顶部肝癌-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、第24卷第l3期China中Jo国ur现na代lo医fM学od杂er志nMedicineV01.24No.132014年5月Mav2014文章编号:1005—8982(2014)13—0085-05人工液胸或气胸辅助氩氦刀治疗膈顶部肝癌范永刚,刘可峰,王伟,姚国良,翟景明,封冰,漫彦文(河南科技大学第一附属医院普外科,河南洛阳471000)摘要:目的探讨人工液胸或气胸技术辅助氖氦刀冷冻消融治疗膈顶部肝癌的临床疗效及分析。方法73例无手术指征膈顶部肝癌患者接受了经肝动脉栓塞化疗(Transcatheterarte
2、ria1chemoembolizati0n。TACE)联合氩氦刀冷冻消(argon-heliumcryosurgerysystem,AHCS)治疗。其中,A组38例患者共46个病灶在彩超引导下采用人工液胸或气胸技术辅助进行,B组35例患者共43个病灶无人工液胸或气胸技术辅助,治疗结束后评价近期疗效,并随访生存情况。结果治疗后两组患者外周血AFP值均较术前出现明显下降(P<0.01),术后A组外周血AFP值远低于B组(P3、显著性(P4、图分类号:R657.3文献标识码:BCryoablationtherapywiththeaidofartificialhydrothoraxorpneumothoraxtotreathepatocellularcarcinomaadjacenttothediaphragmFANYong-gang,LIUKe-feng,WANGWei,YAOGuo—liang,FENGBing,MANYan—wenrs£DepartmentofGeneralSurgery,theFirstAfiliatedHospitalofH5、enanScienceandTechnologyUniversity,Luoyang,Henan471003,P.R.China)Abstract:【objective】Toexploretheclinicalcurativeofargon—heliumcryosurgerysystemforlivercancerlo—catedunderthediaphragmwiththeaidofartificialhydrothoraxorpneumothorax.【Methods】73caseswithoutope卜6、ationindicationofdiaphragmhepatocellularcarcinomaweretreatedwithtranscatheterarterialchemoembolizationandargon—heliumcryosurgerysystem.Agroupof38patientswith46lesionsinultrasoundguidedbyassistedartifi—cialhydrothoraxorpneumothorax.Bgroupof35patientswith43les7、ionswithoutartificia1hydrothoraxorpneumotho—raxtechnicalassistance.therecentcurativeeffectwasevaluatedafterthetreatment,andwerefollowedforsurviva1.【Results】ThepefipherMbloodAFPvaluesweresignificantlessthanthoseofpreoperativeaftertreatmentInthetwogroups(P<0.O8、1),theperipheralbloodAFPvalueofAgroupwasmuchlowerthanthatofBgroupafteroperation(P<0.05).ThetumornecrosisrateofAgroupwasmuchhigherthanthatofBgroup,butnotthecompletenecrosisrate,partialnecrosisrat
3、显著性(P4、图分类号:R657.3文献标识码:BCryoablationtherapywiththeaidofartificialhydrothoraxorpneumothoraxtotreathepatocellularcarcinomaadjacenttothediaphragmFANYong-gang,LIUKe-feng,WANGWei,YAOGuo—liang,FENGBing,MANYan—wenrs£DepartmentofGeneralSurgery,theFirstAfiliatedHospitalofH5、enanScienceandTechnologyUniversity,Luoyang,Henan471003,P.R.China)Abstract:【objective】Toexploretheclinicalcurativeofargon—heliumcryosurgerysystemforlivercancerlo—catedunderthediaphragmwiththeaidofartificialhydrothoraxorpneumothorax.【Methods】73caseswithoutope卜6、ationindicationofdiaphragmhepatocellularcarcinomaweretreatedwithtranscatheterarterialchemoembolizationandargon—heliumcryosurgerysystem.Agroupof38patientswith46lesionsinultrasoundguidedbyassistedartifi—cialhydrothoraxorpneumothorax.Bgroupof35patientswith43les7、ionswithoutartificia1hydrothoraxorpneumotho—raxtechnicalassistance.therecentcurativeeffectwasevaluatedafterthetreatment,andwerefollowedforsurviva1.【Results】ThepefipherMbloodAFPvaluesweresignificantlessthanthoseofpreoperativeaftertreatmentInthetwogroups(P<0.O8、1),theperipheralbloodAFPvalueofAgroupwasmuchlowerthanthatofBgroupafteroperation(P<0.05).ThetumornecrosisrateofAgroupwasmuchhigherthanthatofBgroup,butnotthecompletenecrosisrate,partialnecrosisrat
4、图分类号:R657.3文献标识码:BCryoablationtherapywiththeaidofartificialhydrothoraxorpneumothoraxtotreathepatocellularcarcinomaadjacenttothediaphragmFANYong-gang,LIUKe-feng,WANGWei,YAOGuo—liang,FENGBing,MANYan—wenrs£DepartmentofGeneralSurgery,theFirstAfiliatedHospitalofH
5、enanScienceandTechnologyUniversity,Luoyang,Henan471003,P.R.China)Abstract:【objective】Toexploretheclinicalcurativeofargon—heliumcryosurgerysystemforlivercancerlo—catedunderthediaphragmwiththeaidofartificialhydrothoraxorpneumothorax.【Methods】73caseswithoutope卜
6、ationindicationofdiaphragmhepatocellularcarcinomaweretreatedwithtranscatheterarterialchemoembolizationandargon—heliumcryosurgerysystem.Agroupof38patientswith46lesionsinultrasoundguidedbyassistedartifi—cialhydrothoraxorpneumothorax.Bgroupof35patientswith43les
7、ionswithoutartificia1hydrothoraxorpneumotho—raxtechnicalassistance.therecentcurativeeffectwasevaluatedafterthetreatment,andwerefollowedforsurviva1.【Results】ThepefipherMbloodAFPvaluesweresignificantlessthanthoseofpreoperativeaftertreatmentInthetwogroups(P<0.O
8、1),theperipheralbloodAFPvalueofAgroupwasmuchlowerthanthatofBgroupafteroperation(P<0.05).ThetumornecrosisrateofAgroupwasmuchhigherthanthatofBgroup,butnotthecompletenecrosisrate,partialnecrosisrat
此文档下载收益归作者所有